Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 76 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 11/16/15
End: 08/01/19
Due: 08/01/20
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 05/01/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 05/18/21
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 01/06/20
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 08/30/22
End: 07/31/23
Due: 07/31/24
A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 10/02/18
End: 07/31/21
Due: 07/31/22